Instant blood-mediated inflammatory reaction (IBMIR) causes rapid islet loss in portal vein islet transplantation. Endothelial cells are known to protect against complement-mediated lysis and activation of coagulation. We tested composite pig islet-human endothelial cell grafts as a strategy to overcome IBMIR. Porcine islets were cocultured with human endothelial cells in specially modified culture medium composed of M199 and M200 for 1-9 days. A positive control group, negative control group, and the endothelial cell-coated group were examined with an in vitro tubing loop assay using human blood. The endothelial cell-coated group was subdivided and analyzed by degree of surface coverage by endothelial cells (≤50% vs. >50%) or coculture time (<5 days vs. ≥ 5 days). Platelet consumption and complement and coagulation activation were assessed by platelet count, C3a, and thrombin-antithrombin complex (TAT), respectively. After 60-min incubation in human blood, the endothelial cell-coated group showed platelet consumption inhibition and low C3a and TAT assay results compared to uncoated controls. When the endothelial cell-coated group was subdivided by degree of surface coverage, the ≤50% coated group showed less platelet consumption and less activation of complement and coagulation compared with the positive control (uncoated) group. On analysis by coculture time, only the subgroup cocultured for <5 days showed the same protective effect. Human endothelial cell-coated pig islets, especially the partially coated and short-term cocultured pig islet-human endothelial cell composites, reduced all components of IBMIR. If the optimal endothelial cell-islet coculture method could be identified, human endothelial cell coating of pig islets would offer new strategies to improve xenogenic islet transplantation outcomes.
INTRODUCTION
commonly used agent in clinical islet transplantation. However, administration of heparin may cause complications such as bleeding (19) and lacks the ability to In the clinical setting, pancreatic islet transplantation is performed via the portal vein. The majority of transinhibit complement activation of xenogeneic IBMIR (4). Coating of pig islets with human endothelial cells planted human islets are destroyed before engraftment (11) by instant blood-mediated inflammatory reaction might have several advantages to overcome IBMIR. First, the endothelial lining of blood vessels can endure (IBMIR) (3), which may even be stronger in the setting of xenografts because of species barrier (2,4). direct contact with blood under normal conditions (15). In addition, human endothelial cells coating of pig islets Many strategies have been developed for overcoming IBMIR. Among these, heparin treatment is the most may hide cross-species molecular incompatibilities. Sec-32 KIM ET AL.
ond, endothelial cells have potent effects on angiogenharvested using 1× trypsin-EDTA (GIBCO BRL, Invitrogen). The HAEC were washed with M200 medium, esis (9,13), which should provide a synergistic effect on islet engraftment. Third, inhibition of the interaction becentrifuged at 180 × g for 5 min using a 14-ml Falcon tube (Becton-Dickinson Labware, Lincoln Park, NJ, tween pig islets and human blood will result in decreased inflammation, reducing the severity of rejection USA), and counted in a Burker chamber. After washing, the HAEC were suspended in M200 medium to 3 × 10 6 later in the course (5). Previously, composite human islet-endothelial cell grafts showed beneficial effect in an cells/ml. Ten thousand islet equivalents (IEQ) were mixed together with 3 × 10 6 HAEC in 300 µl modified in vitro model for investigating allogeneic IBMIR (8). Thus, we investigated whether coating of pig islets with culture medium. The mixture was incubated for 1.5 h at room temperature and mixed gently with pipetting every human endothelial cells can inhibit IBMIR in xenograft environment.
15 min. Coated islets were transferred to 150-mm petri dishes before transplantation and cultured for 1-9 days.
MATERIALS AND METHODS
The coverage of each islet with endothelial cells was Islet Isolation and Culture examined under fluorescent microscopy and calculated with an image analysis program (i-solution ver7.3, IMT, The pancreases of adult market pigs were harvested Korea). at the local slaughterhouse. The splenic lobe of the gland was rapidly dissected ex situ, immersed in UW solution,
In Vitro Tubing Loop System and transported to the islet-processing laboratory. PanBlood donors were healthy without specific disease creatic islet isolation and purification were performed as and had no medication history for 1 month before donapreviously described (10). The islets were cultured freetion. The protocol was approved by the Institutional Refloating in standard culture medium (M199; GIBCO view Board of Seoul National University Hospital and BRL, Grand Island, NY, USA) supplemented with Earle's each subject submitted written informed consent. salts, L-glutamine, 2200 mg/L sodium bicarbonate, 25
A modified tubing loop model (3,7) was used for in mM HEPES buffer, and 10% pig serum. Culture mevitro simulation of portal flow. Using an 18-gauge needle, dium was changed every second day. Modified islet culfresh human blood was collected in a surface-heparinture medium was manufactured for coculture, and was ized 60-ml syringe (Corline Systems AB, Uppsala, Swemade up of M199 and M200 (Cascade Biologics, Portden). This blood was transferred to a polyvinyl chloride land, OR, USA) supplemented with the low serum (PVC) tube heparinized on the inner surface (Corline growth supplement (LSGS) kit (Cascade Biologics).
Systems AB) (diameter 6.3 mm, length 390 mm) via a In Vitro Test of Islet Function surface heparinized silicon tube. Each PVC tube was filled with 7 ml of fresh human blood; 100 µl of PBS Glucose-stimulated insulin release was measured and was added as a negative control, 5000 IEQ of uncoated expressed as the stimulation index (10), calculated as the islets in 100 µl of PBS were added as a positive control, ratio of stimulated (16.7 mM glucose) to basal (1.67 mM and 5000 IEQ of endothelial cell coated islets were glucose) insulin release during 60 min of static incubaadded as the treatment group. The loops were then tion in Krebs' Ringer bicarbonate HEPES buffer. Insulin closed and placed in a 37°C incubator on a rocking aplevels were determined with an insulin immunoradiomeparatus. Blood was sampled at 0, 5, 15, 30, and 60 min. tric assay kit (Biosource, Nivelles, Belgium).
For the zero time samples, the blood was transferred Endothelial Cell Preparation directly to EDTA-containing tubes and 1 ml of blood acquired from the tubing loop was placed in an EppenHuman aortic endothelial cells (HAEC; Cascade Biodorf tube containing 40 µl of 0.2 M EDTA. About 100 logics) were cultured at 37°C in 5% CO 2 in M200 meµl of blood was used for full blood count analysis, and dium containing 10% FCS, 100 µg/ml penicillin/streptothe remaining blood was centrifuged at 4000 × g for 20 mycin, and 15 mg/ml of LSGS. Cells were grown to min at 4°C. After 1-h incubation, all the loop contents confluence in 100-mm petri dishes. Medium was changed were filtered through 70-µm diameter filters (Filcons, every second day. HAEC were used from passages 4-7.
Cuptype; DAKO, Glostrup, Denmark 
RESULTS

Statistical Analysis In Vitro Tests of Islet Function in Various For comparison between different blood donors,
Culture Conditions platelet counts were transformed to a percentage of the zero time value. C3a and TAT assay results were trans-
The stimulation index of uncoated pig islets in M199 medium was 1.98 ± 0.19 (mean ± SEM, n = 5). Unformed to a percentage of the positive control value. Data are presented as mean ± SEM. Mean values were coated islets in modified culture medium showed similar glucose-stimulated release values (1.95 ± 0.27, n = 5) to compared using the paired Student t-test. Bonferroni correction was used for subgroup analysis by multiplythose in M199 medium and the endothelial cells coating to coat pig islets was 10 times higher than that used to coat human islets. After 1-9 days of coculture, 3.5-94.5% of coverage was observed (Fig. 1) . The degree of coverage was well correlated with the duration of coculture.
Blood Clot Formation
Blood clot formation as a result of IBMIR was observed after 1-h incubation (Fig. 2) . The volume of blood clot correlated with decreased platelet, monocyte, and granulocyte counts. The clot diameter was 11.25 ± 0.80 mm in the positive control (n = 18), 0.86 ± 0.1 mm in the negative control (n = 18), and 9.12 ± 0.69 mm in the endothelial cell coated group (p = 0.06, n = 17). The >50% coverage (10.25 ± 0.92 mm, p = 0.328, n = 6), although this difference was not significant (Fig. 2) . Because the majority of the subgroup of coated islets with procedure had no harmful effect on insulin secreting ca-≤50% coverage belonged to the subgroup cocultured for pacity of pig islets (1.96 ± 0.29, n = 5).
<5 days, clot formation was more inhibited in the subEndothelial Cell Coating of Pig Islets group cocultured for <5 days compared to the subgroup cocultured for ≥ 5 days. In a single-species model (8) using composite human islet-endothelial cells grafts, the endothelial cells grew Hematologic Analyses until they reached confluence. However, in our twospecies model, human endothelial cells grew very
The positive control group showed exhausted platelets and decreased lymphocyte, monocyte, and granuloslowly on pig islets. This necessitated increase of coculture time and the ratio of endothelial cells to islets in the cyte counts (Table 1 ). The endothelial cell coated group as a whole showed a protective effect on the platelet mixing procedure. The number of endothelial cells used 
Lymphocytes 100%* 95.2 ± 1.7% 82.9 ± 3.4% 89.1 ± 2.6% 93.6 ± 1.7% 81.9 ± 5.2% Monocytes 100%* 105.1 ± 7.3% 21.4 ± 4.3% 40.6 ± 8.9% § 44.8 ± 13.4% 34.0 ± 9.5% Granulocytes 100%* 98.2 ± 0.8% 34.3 ± 2.5% 56.0 ± 5.2% § 58.9 ± 6.7% § 51.5 ± 8.4% Platelets 100%* 56.7 ± 2.0% † 2.1 ± 0.4% 14.5 ± 4.7% § 22.5 ± 6.8% ¶ 8.9 ± 4.4% C3a 1.16 ± 0.65% 42.5 ± 3.8% 100% ‡ 83.1 ± 4.3% § 80.1 ± 5.3% § 88.7 ± 7.7% TAT 0.01 ± 0.00% 5.7 ± 1.5% 100% ‡ 56.2 ± 8.0% § 46.6 ± 6.8% § 71.4 ± 16.7%
Values are mean ± SEM. C3a, complement C3a; TAT, thrombin-antithrombin complex. *The initial baseline count was defined as 100%. Subsequent values were expressed as a percentage of this value. †Decreased by air and tube contact interaction with blood. ‡The final result of the positive control was defined as 100% and other values were expressed as a percentage of this value. §Significant difference (p < 0.01) by Student paired t-test compared with positive control. ¶Significant difference (p < 0.05) by Student paired t-test compared with positive control.
count compared with the positive control (p < 0.01), and the ≤50% coated subgroup also showed a statistically significant protective effect on the platelet count (p < 0.05), whereas the >50% coated subgroup did not (Fig.  3A) . Similar results were observed only in the subgroup of cocultured for <5 days.
C3a and TAT ELISA Assays
The endothelial cell-coated group showed significantly decreased complement (p < 0.01) and coagulation (p < 0.01) activation compared to the uncoated group (Table 1) . Subgroup analysis showed that the ≤50% coated subgroup also showed a significant decrease in both assays, whereas the >50% coated subgroup did not (Fig. 3B, C) . Similar results were observed in the subgroup analysis of coculture time.
DISCUSSION
Whereas complement activation mainly occurs secondary to the activation of the coagulation system in allogeneic IBMIR (16) , porcine islets in human blood trigger direct complement activation (4,7). Because endothelial cells express various surface protectants such as complement regulatory protein, heparan sulfate, antithrombin III, tissue factor pathway inhibitor, and thrombomodulin, it prevents activation of complement cascade and coagulation cascade (15). In addition, endothelial cells prevent platelet aggregation by the release of prostacyclin, ectoADPases, thrombomodulin, nitric oxide, and platelet-derived ADP (15). Furthermore, human endothelial cells coating of pig islets may reduce thrombotic and inflammatory reaction affected by cross-species molecular incompatibilities in the pig to human islet xenotransplantation, because human endothelial cells express human specific surface protectants such as complement regulatory protein, tissue factor pathway inhibitor, and thrombomodulin (2,6). In this study, we found human endothelial cell coating of pig islet reduced all components of xenogeneic IBMIR. Furthermore, there was no harmful effect of modified culture medium and endothelial cell coating of pig islets on insulin-secreting capacity of islets.
The size of blood clot may reflect therapeutic efficiency of the specific strategy chosen for islet protec- In this study, the protective potency of the subgroup of islets with ≤50% endothelial cell coverage was simi-lar to that of human islets covered to 50% with endothe-REFERENCES lial cells in the previous allogeneic IBMIR (8). How- changes including loss of surface heparin sulfate, en-
